Detailed Explanation
The parallel-group design is the most common clinical trial architecture, in which participants are randomized to receive a single treatment for the duration of their participation while other groups concurrently receive alternative treatments or placebo. Each participant contributes data to only one treatment group, and comparisons are made between the groups rather than within individual participants. This straightforward design is applicable to virtually any therapeutic context and can accommodate any number of treatment arms.